Anxiety sensitivity as a predictor of outcome in the treatment of obsessive-compulsive disorder by Blakey, Shannon M. et al.
lable at ScienceDirect
J. Behav. Ther. & Exp. Psychiat. 57 (2017) 113e117Contents lists avaiJournal of Behavior Therapy and
Experimental Psychiatry
journal homepage: www.elsevier .com/locate / jbtepAnxiety sensitivity as a predictor of outcome in the treatment of
obsessive-compulsive disorder
Shannon M. Blakey a, *, Jonathan S. Abramowitz a, Lillian Reuman a, Rachel C. Leonard b,
Bradley C. Riemann b
a University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
b Rogers Memorial Hospital, Oconomowoc, WI, United Statesa r t i c l e i n f o
Article history:
Received 8 April 2016
Received in revised form
20 February 2017
Accepted 2 May 2017
Available online 6 May 2017* Corresponding author. University of North Carolin
(Davie Hall), Chapel Hill, NC 27599, United States.
E-mail address: sblakey@unc.edu (S.M. Blakey).
http://dx.doi.org/10.1016/j.jbtep.2017.05.003
0005-7916/© 2017 Elsevier Ltd. All rights reserved.a b s t r a c t
Background and objectives: To address the fact that not all individuals who receive cognitive-behavioral
therapy (CBT) for obsessive-compulsive disorder (OCD) exhibit complete symptom reduction, research
has examined factors that predict outcome; however, no studies have examined anxiety sensitivity (AS)
as a predictor of outcome of CBT for OCD. AS refers to the fear of anxious arousal that results from
mistaken beliefs about the dangerousness of anxiety-related body sensations. It is important to under-
stand whether AS influences OCD treatment outcome, considering that (a) some obsessions directly
relate to AS, and (b) OCD patients with high AS may be reluctant to engage in anxiety-provoking
components of CBT for OCD.
Methods: Patients (N ¼ 187) with a primary diagnosis of OCD who received residential CBT for OCD
participated in this study, which involved completing a self-report battery at pre- and post-treatment.
Results: Results supported study hypotheses, in that (a) baseline AS positively correlated with baseline
OCD severity, and (b) greater baseline AS prospectively predicted higher posttreatment OCD symptom
severity even after controlling for pretreatment OCD and depression severity.
Limitations: The study was limited by its use of an older measure of AS, reliance on self-report measures,
and nonstandardized treatment across participants.
Conclusions: Findings highlight the importance of AS in the nature and treatment of OCD. Clinical im-
plications and future directions are discussed.
© 2017 Elsevier Ltd. All rights reserved.Obsessive-compulsive disorder (OCD) is characterized by dis-
tressing, unwanted intrusive thoughts, images, and doubts (i.e.,
obsessions) and/or urges to perform repetitive, deliberate rituals
and other anxiety-reduction strategies to neutralize this distress
(i.e., compulsions) (American Psychiatric Association [APA], 2013).
Compulsive rituals are reinforced by the immediate decrease in
anxiety they engender, yet the anxiety reduction is temporary and
compulsions prevent the natural extinction of obsessional fear in
the long term. Obsessive-compulsive symptoms cause considerable
distress and functional impairment among the 2e3% of the popu-
lation that experiences OCD at some point in their lifetime (Kessler
et al., 2005).
Cognitive-behavioral therapy (CBT) using exposure anda at Chapel Hill, C.B. # 3270response prevention (ERP) procedures can be an effective treat-
ment for OCD (e.g., Olatunji, Cisler, & Deacon, 2010). Exposure
entails repeated systematic confrontation with situations and
stimuli that provoke obsessional anxiety; response prevention in-
volves resisting urges to perform escape and avoidance behaviors
(e.g., compulsive rituals) during and after exposure trials. Yet
despite its established efficacy, response to this intervention varies
widely and some individuals are not able to adhere or respond.
Accordingly, researchers have sought to identify factors that predict
outcome. Severe depression and baseline OCD symptoms, for
example, have been associated with attenuated response to CBT for
OCD across a large body of research (Abramowitz & Foa, 2000;
Abramowitz, Franklin, Kozak, Street, & Foa, 2000; Farrell et al.,
2016; Foa et al., 1983; Knopp, Knowles, Bee, Lovell, & Bower,
2013; Steketee, Chambless, & Tran, 2001), although the relation-
ship between baseline depression and OCD treatment outcome is
not consistent and does not appear to influence outcomes in the
Table 1
Secondary diagnosis of study participants.
Secondary diagnosis n (%)
Mood disorders 62 (33.2)
Major depressive disorder 10 (5.3)
Bipolar I disorder 1 (0.5)
Other mood disorder 51 (27.3)
Anxiety-related disorders 36 (19.3)
Panic disorder 4 (2.1)
Posttraumatic stress disorder 1 (0.5)
Social anxiety disorder 10 (5.3)
General anxiety disorder 21 (11.2)
Obsessive-compulsive and related disorders 5 (2.7)
Trichotillomania 1 (0.5)
Tic disorder/Tourette's syndrome 1 (0.5)
Body dysmorphic disorder 3 (1.6)
Developmental disorders 2 (1.1)
Attention deficit/hyperactivity disorder 1 (0.5)
Learning disability 1 (0.5)
Eating disorders 3 (1.6)
Anorexia nervosa 1 (0.5)
Bulimia nervosa 1 (0.5)
Other eating disorder 1 (0.5)
Other psychological disorder 45 (24.1)
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To date, no studies have examined anxiety sensitivity (AS) as a
predictor of CBT outcome in OCD. AS refers to mistaken beliefs
about the dangerousness of anxiety-related body sensations that
generate the fear of anxious arousal (e.g., Reiss & McNally, 1985).
Specifically, individuals with elevated AS are hypervigilant to and
(mis)appraise ambiguous body sensations as particularly
dangerous. For example, someone with high anxiety sensitivity
might misinterpret chest tightness as a sign of a heart attack,
dizziness as a sign of “losing control,” or racing thoughts as an in-
dicator that one is “going crazy” and about do something embar-
rassing or harmful. Although AS is often associated with panic
disorder, it is considered a transdiagnostic process (Taylor, 1999);
moreover, AS has demonstrated moderate to strong associations
with OCD symptom severity in individuals diagnosed with OCD
(Pearson rs range 0.28e0.30; partial rs range 0.28e0.64; Calamari,
Rector, Woodard, Cohen, & Chik, 2008; Deacon & Abramowitz,
2006; Laposa, Collimore, Hawley, & Rector, 2015; Norton, Sexton,
Walker, & Norton, 2005; Zinbarg, Barlow, & Brown, 1997; for a
review see Robinson & Freeston, 2014) as well among nonclinical
individuals (Pearson rs range 0.30e0.56; David et al., 2009;
Keough, Riccardi, Timpano, Mitchell, & Schmidt, 2010; Sexton,
Norton, Walker, & Norton, 2003; Wheaton, Deacon, McGrath,
Berman, & Abramowitz, 2012).
Although research in this area is limited, a few studies have
highlighted relationships between specific dimensions of AS (i.e.,
the fear of anxiety and/or anxious arousal because of feared phys-
ical, mental, or social consequences) and OCD symptoms (e.g.,
Wheaton, Mahaffey, Timpano, Berman, & Abramowitz, 2012). Pre-
vious investigators have posited that the cognitive dimension of AS
in particular is strongly related to OCD given that misappraisals of
one's own thinking (e.g., overestimating the importance of
thoughts) are a cardinal feature of OCD (Rachman, 1997, 1998).
Although some research supports this hypothesis (e.g., Cox, Borger,
& Enns, 1999; Sexton et al., 2003; Wheaton et al., 2012), aggregate
findings are inconsistent (Deacon & Abramowitz, 2006). Moreover,
the cross-sectional nature of previous studies precludes in-
vestigators from determining whether AS predicts changes in OCD
symptom severity over time (e.g., following treatment).
There are a number of reasons to examine AS as a predictor of
poorer outcome with CBT for OCD. First, anxious arousal is often
provoked during exposure therapy. Thus, individuals with high AS
are apt to become afraid not only of exposure stimuli per se, but
also the arousal sensations induced when conducting exposures.
Given that AS is a strong predictor of panic attacks (e.g., Schmidt,
Zvolensky, & Maner, 2006), OCD patients with high AS might be
prone to experiencing panic episodes during exposure, which could
lead to avoidance behavior and hamper both adherence and con-
fidence in the treatment techniques, thereby leading to suboptimal
outcome. Furthermore, some patients’ obsessions might directly
relate to ambiguous somatic sensations; for example, a patient who
presents with contamination-related OCD may be especially
hypervigilant for (and anxious in response to) feelings of nausea,
which often accompany anxious arousal.
One methodological obstacle to examining predictors of
outcome in OCD is that patients with high levels of concurrent
anxiety and depression (i.e., comorbidity) are often excluded from
randomized controlled trials (RCTs) in efforts to maximize the in-
ternal validity of such studies. Yet this restricts the range of co-
morbid psychopathology variables (e.g., depression, AS),
potentially obscuring relationships in secondary analyses of
outcome predictors. We addressed this issue in the present inves-
tigation by using a large sample of individuals with OCD seeking
treatment outside the context of an RCT. Our data were collected
within a residential program specializing in CBT for OCD in whichindividuals often met criteria for comorbid conditions (e.g., major
depression) and were concurrently using psychotropic medication.
Although these sample characteristics might attenuate internal
validity (e.g., treatment was less standardized than in controlled
studies), it afforded the best opportunity to observe the effects of
AS on CBT response in a diverse OCD clinical sample receiving CBT
in a service setting.
The present study was designed to examine the extent to which
baseline levels of AS predict treatment outcome in a sample of
individuals with a clinical diagnosis of OCD undergoing CBT above
and beyond established predictors of attenuated response (i.e.,
baseline OCD and depressive symptom severity). On the basis of
previous research and the conceptual considerations noted above,
we expected that baseline AS would be positively correlated with
baseline OCD severity. We also hypothesized that greater baseline
levels of AS would prospectively predict higher posttreatment OCD
symptom severity above and beyond pretreatment OCD and
depression severity.
1. Method
1.1. Participants
Participants were considered eligible to participate in the cur-
rent study if they (a) had a primary diagnosis of OCD, (b) were
admitted for residential treatment at the Obsessive-Compulsive
Disorders Center at Rogers Memorial Hospital (RMH) in Ocono-
mowoc, Wisconsin, (c) provided informed consent to participate,
and (d) had completed pre- and post-treatment assessments. Pa-
tients with comorbid psychotic symptoms or current substance
abuse were considered ineligible. On average, approximately 28.5 h
of ERP were completed per week, including both staff-assisted and
self-directed exposure practice. Most participants (n ¼ 163; 87.2%)
were also taking psychiatric medications; primarily, selective se-
rotonin reuptake inhibitors (SSRIs; n ¼ 125; 66.8%). Psychiatric
medications were adjusted upon the on-site psychiatrist's assess-
ments of the patient's needs (information on the precise number of
participants whose medication changed during the course of CBT
was unfortunately not available). The majority (n ¼ 153; 81.8%) had
secondary diagnoses, which are shown in Table 1.
The final sample included 187 adults (51.9% women; n ¼ 97)
who had a mean age of 30.49 years (SD ¼ 12.24) and had received
Table 2
Zero-Order bivariate correlations among study variables.
Variable 1 2 3 4 5 6
1. Posttreatment DOCS e
2. Baseline DOCS 0.52 e
3. Baseline BDI-II 0.26 0.36 e
4. Baseline ASI-Total 0.45 0.39 0.42 e
5. Baseline ASI-Physical 0.41 0.31 0.26 0.86 e
6. Baseline ASI-Mental 0.35 0.27 0.48 0.76 0.45 e
7. Baseline ASI-Social 0.35 0.40 0.41 0.92 0.67 0.66
DOCS ¼ Dimensional Obsessive-Compulsive Scale; BDI-II ¼ Beck Depression
Inventory-II; ASI ¼ Anxiety Sensitivity Index; all ps < 0.01.
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participants (n ¼ 167; 89.3%) identified as White/European Amer-
ican, with 3.7% (n ¼ 7) identifying as Asian and 1.1% (n ¼ 2) iden-
tifying as African American. Eight (4.3%) participants self-identified
as being of Hispanic origin. Three participants (1.6%) did not self-
disclose their race/ethnicity. Most participants (n ¼ 128; 68.4%)
were single; 24.6% (n ¼ 46) were married and 2.1% (n ¼ 4) were
divorced (marital status was undocumented for two participants).
1.2. Procedure
1.2.1. Assessment
Prior to admission to the residential treatment program, all
prospective patients completed an initial assessment with a trained
intake staff member. This included the clinician-rated version of the
semi-structured Yale-Brown Obsessive-Compulsive Scale (Y-BOCS;
Goodman, Price, Rasmussen, & Mazure, 1989a, 1989b) symptom
checklist and severity rating to determine the presence of DSM-IV
OCD (APA, 2000). The clinical director of the Obsessive-
Compulsive Disorder Center ([AUTHOR INITIALS]) reviewed the
results of this assessment with the intake interviewer and deter-
mined if the patient was appropriate for admission. Individuals
were only admitted to the clinic for treatment, and thus included in
the current study, if there was 100% diagnostic agreement between
the intake interviewer and clinical director. Each participant also
completed a self-report assessment packet that included the study
measures described further below, which was re-administered at
posttreatment. As part of the admissions process, patients provided
consent to allow their responses to the study measures to be used
for both clinical and research purposes. The consent procedures
and study measures were approved by both the RMH Human
Subjects Committee and the Rogers Center for Research and
Training.
1.2.2. Treatment
Treatment consisted of ERP, which followed the procedures
described by Kozak and Foa (1997). Therapists and participants
developed a list of situations for exposure that triggered their
anxiety from least to most feared and then assisted participants in
facing these feared situations in a prolonged, repetitive, and grad-
uated manner while at the same time helping them to resist
engaging in avoidance behaviors and/or rituals. Participants also
engaged in cognitive restructuring to help them examine and
disconfirm their irrational beliefs. Additional interventions (e.g.,
behavioral activation for symptoms of depression) were often used
to address comorbid symptoms. Further, participants met regularly
with their therapist for non-CBT work (e.g., psychoeducation with
family members), participated in a process group once per week,
and participated in experiential therapy groups several times per
week.
1.3. Measures
1.3.1. Dimensional Obsessive-Compulsive Scale (DOCS; Abramowitz
et al., 2010)
The DOCS is a 20-item self-report measurewith four empirically
derived subscales that assesses the severity of the four most
consistently replicated OCD symptom dimensions: (a) contamina-
tion (DOCS-C), (b) responsibility for harm and mistakes (DOCS-H),
(c) unacceptable thoughts (DOCS-UT), and (d) symmetry/ordering
(DOCS-S). Each subscale begins with a description of the symptom
dimension as well as prototypical examples of fears, rituals, and
avoidance behaviors. Next, within each symptom dimension, five
items (rated 0 to 4) assess the following parameters of severity: (a)
time occupied by obsessions and rituals, (b) avoidance behavior, (c)associated distress, (d) functional interference, and (e) difficulty
disregarding the obsessions and refraining from the compulsions.
The DOCS has demonstrated excellent reliability in clinical samples
(a ¼ 0.94-0.96), and the measure converges well with other mea-
sures of OCD symptoms (Abramowitz et al., 2010).
1.3.2. Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown,
1996)
The BDI-II is a 21-item self-report scale that assesses the severity
of affective, cognitive, motivational, vegetative, and psychomotor
components of depression. Scores of 10 or less are considered
normal; scores of 20 or greater suggest the presence of clinical
depression. The BDI-II has excellent reliability and validity and is
widely used in clinical research (Beck et al., 1996).
1.3.3. Anxiety Sensitivity Index (ASI; Reiss, Epstein, & Gursky, 1986)
The ASI is a unidimensional 16-item self-report measure of
beliefs regarding the dangerousness of anxious arousal (e.g., “It
scares me when my heart beats rapidly”). Participants rate their
agreement with each statement on a 0 (very little) to 4 (very much)
scale; higher scores indicate greater AS. The ASI has demonstrated
adequate reliability and validity in previous research (Peterson &
Reiss, 1992; Reiss, Peterson, Gursky, & McNally, 1986). Three ASI
subscales were computed according to the principal components
solution recommended by Taylor, Koch, Woody, and McLean
(1996): ASI-Physical Concerns (items 6, 7, 8, 9, 10, and 11; Cron-
bach a ¼ 0.81), ASI-Mental Concerns (items 2, 12, and 15; Cronbach
a ¼ 0.80), and ASI-Social Concerns (items, 1, 3, 4, 5, 13, 14, and 16;
Cronbach a ¼ 0.75).
2. Results
Data were first screened to assess concordance with statistical
assumptions. Distributions of scores on study measures were free
of significant skew and kurtosis (all values < 2). DOCS, ASI, and BDI-
II scores fell within the range of expected values. The sample
exhibited clinically significant baseline AS (M ¼ 23.94; SD ¼ 12.28)
and depressive symptoms (M ¼ 26.28; SD ¼ 13.47) prior to treat-
ment. The sample's mean DOCS total score indicated clinically
significant OCD symptom severity prior to treatment (M ¼ 32.73;
SD¼ 15.07). At posttreatment, themean DOCS total score was 16.59
(SD ¼ 11.74). A paired-samples t-test revealed that the change in
DOCS total scores from pre-to posttreatment was significant,
t(123) ¼ 13.22, p < 0.001, d ¼ 1.18.
To test our first hypothesis that AS would be associated with
baseline OCD symptoms, we computed zero-order correlations
between ASI total and subscale scores and pretreatment DOCS total
scores. Correlations among study variables are presented in Table 2.
These analyses revealed significant positive correlations among
pretreatment DOCS and ASI total and subscale scores (all
ps < 0.001).
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scales would predict posttreatment OCD symptom severity above
and beyond baseline OCD and depressive symptom severity, we
computed a hierarchical linear regressionmodel. Results are shown
in Table 3.
In Step 1, baseline DOCS (to control for pretreatment OCD
severity) and BDI-II (to control for depressive symptom severity)
scores jointly explained a significant amount of variance (28.62%) in
posttreatment DOCS scores, F(2, 106) ¼ 21.276, p < 0.001. Adding
ASI subscale scores in Step 2 of this model account for statistically
significant additional variance (R2 change ¼ 0.05, p ¼ 0.049), such
that higher pretreatment AS predicted poorer OCD treatment
response even after controlling for pretreatment OCD and depres-
sion severity. However, after accounting for pretreatment DOCS and
BDI-II scores, individual ASI subscales did not uniquely predict
significant variance in posttreatment DOCS scores (i.e., ASI sub-
scales only jointly explained significant outcome variance).
Based on our findings that depressive symptoms were only
moderately correlated with baseline and posttreatment DOCS
scores, we conducted an exploratory hierarchical regression
excluding BDI-II scores, such that baseline DOCS were entered in
Step 1, and the ASI subscales were entered in Step 2 of the model
predicting posttreatment DOCS scores. The pattern of results was
generally consistent with the primary analysis. Specifically, pre-
treatment OCD symptoms explained for a significant amount
(27.2%) of posttreatment OCD symptoms in Step 1, F(1, 108)¼ 41.63,
p < 0.001, yet the addition of the ASI subscales in Step 2 accounted
for an additional 6.0% of outcome variance, FDR2 (3, 105) ¼ 3.15,
p ¼ 0.028. In this simplified model, the ASI physical subscale
accounted for a marginally significant amount of unique outcome
variance, b ¼ 0.198, t(104) ¼ 1.83, p ¼ 0.070, spr2 ¼ 0.021.
3. Discussion
It is important to understand why certain OCD patients do not
adhere or respond to CBT, the gold-standard intervention for OCD.
In this vein, trait levels of AS represent a relevant and promising
predictor of treatment outcome. Accordingly, the current study
examined the extent to which baseline AS predicted treatment
outcome in a sample of individuals with a clinical diagnosis of OCD
undergoing CBT. Consistent with our first hypothesis, AS was
positively correlated with baseline OCD severity. This is in line
with previous work (see Robinson & Freeston, 2014) and indicates
that increased fear of arousal-related body sensations is associ-
ated with increased OCD symptom severity. Our second hypoth-
esis, that greater baseline levels of AS would prospectively predict
higher posttreatment OCD symptom severity after controlling for
pretreatment OCD and depression severity (i.e., factors consis-
tently documented to influence OCD treatment response), wasTable 3
Hierarchical linear regression predicting posttreatment DOCS total scores.
D R2 B SEB b t p sr
2
Step 1 0.29 <0.001
Baseline DOCS 0.41 0.07 0.50 5.63 <0.001 0.213
Baseline BDI-II 0.06 0.08 0.08 0.85 0.397 0.005
Step 2 0.05 0.049
Baseline DOCS 0.35 0.08 0.43 4.63 <0.001 0.138
Baseline BDI-II 0.02 0.09 0.02 0.19 0.853 <0.001
ASI-Physical 0.42 0.23 0.20 1.79 0.077 0.021
ASI-Mental 0.64 0.46 0.17 1.40 0.166 0.013
ASI-Social 0.15 0.28 0.07 0.54 0.590 0.002
DOCS ¼ Dimensional Obsessive-Compulsive Scale; BDI-II ¼ Beck Depression
Inventory-II; ASI ¼ Anxiety Sensitivity Index; sr2 ¼ squared semipartial correlation.also supported. Even after controlling for pretreatment OCD and
depression severity (which did not significantly predict CBT
treatment outcome in our sample), the construct of AS accounted
for significant, incremental variance in posttreatment OCD
severity; although, no individual AS dimension emerged as a
unique predictor. This suggests that the fear of anxious arousal in
general predicts the outcome of CBT for OCD, and therefore rep-
resents a promising target for enhancing treatment response.
An important next step is to consider the mechanism through
which AS hinders the effects of CBT for OCD. Although it was not
measured directly in the present study, we hypothesize that
elevated AS served to amplify exposure difficulty. Specifically,
exposures that generated sensations of anxious arousal may have
been experienced as more challenging and/or distressing not only
because of the fear of the stimuli themselves (e.g., “Touching the
toilet will make me sick”), but also because of the threat associ-
ated with physiological arousal (e.g., “If my heart races, I will have
a heart attack”). In effect, OCD patients with high AS are simul-
taneously confronting two conditioned fear stimuli during expo-
sures, which might understandably lead to nonadherence with
prescribed exposure tasks. To test this hypothesis, future work
examining AS as an outcome predictor might include measures of
the quality of engagement in ERP as well as measures of physio-
logical arousal during exposures (e.g., heart rate and skin
conductance).
Regarding clinical implications of our findings, it may be bene-
ficial to first conduct interoceptive exposure (IE; deliberately
inducing feared-yet-safe body sensations without engaging in
arousal-reduction strategies) with high AS patients prior to expo-
sures to OCD-related stimuli with the aim of extinguishing the fear
of arousal-related sensations. This might increase willingness to
comply with ERP procedures for OCD. Consistent with inhibitory
learning approaches to fear extinction, CBT might also involve the
simultaneous use of IE and in vivo exposure to optimize consoli-
dation of long-term extinction learning (e.g., Arch & Abramowitz,
2015; Craske et al., 2008, 2014). For example, a patient who in-
terprets her trembling hands as indicating that she is highly likely
to act on her unwanted obsessional thoughts of stabbing a loved
one might conduct tailored IE exercises (i.e., holding a pushup
position to induce trembling) immediately prior to holding a knife
while near a loved one (in vivo exposure). This procedure is
consistent with the principle of deepened extinction as described
by Rescorla (2006), in which multiple fear cues are combined
during exposure.
Strengths of the present study included the large clinical
sample (which maximizes power) as well as the variability of
patient symptomatology (which offers greater external validity
and sample generalizability than many RCTs). On the other hand,
one limitation of this research was the use of the original ASI
(Reiss et al., 1986), rather than the newer ASI-3 (Taylor et al.,
2007). Second, assessments relied on self-report measures
administered at pre- and posttreatment only; future research
should administer assessments at additional time points, as well
as include clinician-rated assessments of symptom severity. A
third limitation regards the differences in treatment duration and
multimodal intervention at Rogers Memorial Hospital, as well as
the fact that some participants may have had medication adjust-
ments during treatment (if deemed appropriate by the on-site
psychiatrist). Along these lines, it is also possible that patients in
our sample did conduct OCD exposures that in some way
addressed their AS concerns. Finally, because our sample was
receiving residential treatment, our findings may not apply to
routine clinical settings. Thus, future research examining the role
of particular dimensions of AS in various approaches of stan-
dardized CBT for OCD should be conducted.
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